市場調査レポート

商品コード

1792654

網膜手術装置の市場規模、シェア、動向、予測：機器タイプ別、用途別、最終用途別、地域別、2025年～2033年

Retinal Surgery Devices Market Size, Share, Trends and Forecast by Equipment Type, Application, End-Use, and Region, 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 445,111円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 593,531円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 741,951円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.42円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

網膜手術装置の世界市場規模は2024年に22億米ドルとなりました。今後、IMARC Groupは、同市場が2033年までに39億米ドルに達し、2025年から2033年にかけて6.3%のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年には約35%という大きな市場シェアを占めています。この市場を牽引しているのは、人口の高齢化と糖尿病患者の増加により、糖尿病網膜症やAMDなどの網膜疾患の有病率が上昇していることです。微小切開硝子体手術のような低侵襲手術の技術進歩は治療効果を高める。ヘルスケア支出の増加、新興市場における眼科医療へのアクセスの改善、早期診断を促進する政府の取り組みが需要をさらに促進しています。さらに、研究開発投資の増加や革新的な機器の導入が、網膜手術装置市場のシェアをさらに拡大しています。

加齢黄斑変性（AMD）、糖尿病網膜症、網膜剥離などの網膜疾患の有病率の上昇が市場を牽引しています。微小切開硝子体手術（MIVS）などの低侵襲手術技術の進歩は、治療効果と患者の転帰を向上させる。さらに、網膜疾患に罹患しやすい老年人口の増加が市場の需要を促進しています。2080年代の世界人口のピーク103億人を背景に、2080年までに世界の65歳以上の人口は22億人に達し、18歳未満の子供を上回ると予想されています。平均寿命も延びており、2024年の73.3歳から2054年には77.4歳に延び、その結果、高齢者層における眼科医療サービスの需要が増大します。高齢化社会の人口動態の変化は、世界中で急成長している高齢者市場において、視力の健康を改善するための最先端の網膜手術技術への投資が急務であることを示しています。新興国におけるヘルスケア支出の増加と高度な眼科医療へのアクセスの改善は、網膜手術装置市場の成長にさらに貢献しています。政府の支援策や早期診断・治療に対する意識の高まりも市場拡大に大きな役割を果たしています。

米国は主要な地域市場として際立っており、特に高齢化社会の中で慢性的な眼疾患が増加していることが主な要因となっています。40歳以上の米国成人の1,200万人以上が視力障害を患っており、そのうち100万人が失明しています。この数は2050年までに2倍以上になると推定されており、その主な原因は高齢化と糖尿病などの慢性疾患です。視力障害は米国成人の健康問題のトップ10にランクされ、糖尿病性網膜症は予防可能な失明のケースの90%を引き起こしています。視力障害の経済コストは2050年までに3,730億米ドルに達する可能性があるため、このような避けられない障害を治療するための革新的な網膜手術機器に対する需要は高いです。糖尿病患者の増加が糖尿病網膜症治療の需要増に寄与する一方、硝子体手術システムや手術用レーザーの技術革新が治療成績を向上させています。強固なヘルスケアインフラと業界大手の存在が、先端技術の急速な導入を後押ししています。さらに、患者の意識の高まりと積極的なスクリーニングプログラムにより、疾患の早期発見が促進され、外科的介入が改善されます。新規デバイスの規制承認やメーカー間の戦略的提携が市場拡大をさらに刺激し、最先端の網膜手術ソリューションの安定したパイプラインを確保しています。

網膜手術装置市場動向：

眼疾患の有病率の上昇

視力関連疾患の世界の有病率の増加は、マーケット成長の主要な触媒です。黄斑変性症、網膜色素変性症、糖尿病性網膜症などの疾患は、特に世界中の糖尿病患者や高齢者の間で広まっています。これに伴い、糖尿病性網膜症だけでも全世界の糖尿病患者の25.2%が罹患しており、2型糖尿病患者の50%に比べ、1型糖尿病患者（約75%）では発生率が著しく高くなっています。網膜手術装置の市場予測によると、こうした憂慮すべき統計が、効果的かつ効率的な手術ソリューションの需要を押し上げています。精密な治療を必要とする症例の増加により、費用対効果が高く、時間を節約でき、処置の効率が高いとされる網膜手術装置の採用が増加しています。世界の糖尿病人口の増加に伴い、この動向は今後も続くと予想され、市場の拡大を支えています。これを受けて、ヘルスケアプロバイダーは、進行性の眼疾患を効果的に管理するために、早期診断と高度な外科的介入を優先しています。

高齢者人口と加齢に伴う視力低下

世界の人口動態の高齢化も、網膜手術装置市場の需要を高める顕著な要因です。高齢者は白内障、緑内障、老眼など加齢に関連する眼疾患にかかりやすいです。45～54歳では女性の4%、男性の2.4%が罹患しており、75歳以上では女性の30.49%、男性の27.97%に激増します。世界人口の高齢化が進むにつれ、ヘルスケア分野では、高齢患者特有の要件に合わせた高度な外科的介入の必要性が高まっています。網膜手術装置は、痛みの軽減、傷跡の最小化、回復時間の短縮といった大きな利点を提供し、これらは特に高齢者患者にとって魅力的です。慢性的な視力問題に対する脆弱性が増しているこの層は、ヘルスケアシステムと機器メーカーに、高齢者の快適性と安全性を確保しながら治療成績を向上させる技術への投資を促しています。このため、網膜手術装置市場の見通しはさらに明るいものとなっています。

技術の進歩と糖尿病罹患率の上昇

低侵襲手術ツールや機器の技術進歩が、網膜手術装置市場の将来を大きく左右しています。同時に、世界の糖尿病罹患率の急上昇は、専門的な眼科医療ソリューションへのさらなる需要を生み出しています。国際糖尿病連合（IDF）によると、現在約5億8,900万人の成人が糖尿病を患っており、その数は2050年までに8億5,300万人に増加すると予測されています。この慢性疾患は毎年340万人以上の死亡の原因となっており、糖尿病性網膜症や関連する視力問題の症例増加の主な要因となっています。低侵襲手術へのシフトは、患者の予後改善、回復の早さ、安全性の向上を求める広範な動きと一致しています。網膜手術装置の技術革新は、増加する糖尿病患者特有の医療ニーズに対応しながら、これらの利点を提供しています。治療の選択肢に対する認識が世界的に広まるにつれ、この技術革新と健康人口統計の融合が市場成長を後押ししています。

北米
- 米国
- カナダ
アジア太平洋
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場内訳：国別

第10章 SWOT分析

概要
強み
弱み
機会
脅威

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第13章価格指標

第14章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Alcon Management S. A.
- Bausch & Lomb Incorporated
- Carl Zeiss
- Ellex Medical Lasers
- Erbe Elektromedizin
- Escalon Medicals
- Iridex Corporation
- Leica Microsystems GmbH
- Lumenis
- Nidek Co. Ltd.
- Optos PLC
- Second Sigh Medical Products
- Synergetics USA Inc.
- Topcon Corporation

図表

List of Figures

Figure 1: Global: Retinal Surgery Devices Market: Major Drivers and Challenges
Figure 2: Global: Retinal Surgery Devices Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Retinal Surgery Devices Market: Breakup by Equipment Type (in %), 2024
Figure 4: Global: Retinal Surgery Devices Market: Breakup by Application (in %), 2024
Figure 5: Global: Retinal Surgery Devices Market: Breakup by End-Use (in %), 2024
Figure 6: Global: Retinal Surgery Devices Market: Breakup by Region (in %), 2024
Figure 7: Global: Retinal Surgery Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 8: Global: Retinal Surgery Devices (Vitrectomy Machines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Retinal Surgery Devices (Vitrectomy Machines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Retinal Surgery Devices (Surgical Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Retinal Surgery Devices (Surgical Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Retinal Surgery Devices (Retinal Detachment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Retinal Surgery Devices (Retinal Detachment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Retinal Surgery Devices (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Retinal Surgery Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Retinal Surgery Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Retinal Surgery Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Retinal Surgery Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Retinal Surgery Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: North America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: North America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: United States: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: United States: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Canada: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Canada: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Asia Pacific: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Asia Pacific: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: China: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: China: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Japan: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Japan: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: India: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: India: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: South Korea: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: South Korea: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Australia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Australia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Indonesia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Indonesia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Europe: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Europe: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Germany: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Germany: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: France: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: France: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: United Kingdom: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: United Kingdom: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Italy: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Italy: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Spain: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Spain: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Russia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Russia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Latin America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Latin America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Brazil: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Brazil: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Mexico: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Mexico: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Middle East and Africa: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Middle East and Africa: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Global: Retinal Surgery Devices Industry: SWOT Analysis
Figure 75: Global: Retinal Surgery Devices Industry: Value Chain Analysis
Figure 76: Global: Retinal Surgery Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Retinal Surgery Devices Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Retinal Surgery Devices Market Forecast: Breakup by Equipment Type (in Million USD), 2025-2033
Table 3: Global: Retinal Surgery Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Retinal Surgery Devices Market Forecast: Breakup by End-Use (in Million USD), 2025-2033
Table 5: Global: Retinal Surgery Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Retinal Surgery Devices Market: Competitive Structure
Table 7: Global: Retinal Surgery Devices Market: Key Players

Product Code: SR112025A2059

The global retinal surgery devices market size was valued at USD 2.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 3.9 Billion by 2033, exhibiting a CAGR of 6.3% during 2025-2033. North America currently dominates the market, holding a significant market share of around 35% in 2024. The market is driven by the rising prevalence of retinal disorders, including diabetic retinopathy and AMD, fueled by aging population and increasing diabetes cases. Technological advancements in minimally invasive surgeries, such as microincision vitrectomy, enhance treatment efficacy. Growing healthcare expenditure, improved access to eye care in emerging markets, and government initiatives promoting early diagnosis further propel demand. Additionally, increasing R&D investments and the introduction of innovative devices are further expanding the retinal surgery devices market share.

The market is driven by the rising prevalence of retinal disorders such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal detachment. Technological advancements in minimally invasive surgical techniques, such as microincision vitrectomy surgery (MIVS), enhance treatment efficacy and patient outcomes. Additionally, the growing geriatric population, which is more susceptible to retinal diseases, fuels market demand. By 2080, the global number of individuals aged 65 and above is expected to stand at 2.2 billion, outnumbering children under the age of 18, against a background of a peak global population of 10.3 billion in the 2080s. Life expectancy is also increasing, rising from 73.3 years in 2024 to 77.4 years in 2054, resulting in increased demand for eye care services among the elderly population. The changing demographics of the aging population indicate the urgent need for investment in cutting-edge retinal surgery technologies to improve vision health in the fast-growing geriatric markets around the world. Increased healthcare expenditure and improved access to advanced ophthalmic care in emerging economies further contribute to the retinal surgery devices market growth. Supportive government initiatives and increasing awareness about early diagnosis and treatment also play a significant role in expanding the market.

The United States stands out as a key regional market, primarily driven by the rising incidences of chronic eye conditions, particularly among the aging population. Over 12 million U.S. adults aged 40 and older have vision impairment, including 1 million who are blind. The number is estimated to more than double by the year 2050, mostly due to aging and chronic conditions such as diabetes. Vision disability ranks among the leading ten health problems in U.S. adults, with diabetic retinopathy causing 90% of cases of preventable blindness. Since the economic cost of vision impairment is likely to hit USD 373 Billion by 2050, demand for innovative retinal surgery equipment to treat such inescapable disorders is high. Increasing cases of diabetes contribute to higher demand for diabetic retinopathy treatments, while innovations in vitrectomy systems and surgical lasers improve procedural outcomes. Strong healthcare infrastructure and the presence of major industry players drive rapid adoption of advanced technologies. Additionally, heightened patient awareness and proactive screening programs facilitate early disease detection, improving surgical interventions. Regulatory approvals for novel devices and strategic collaborations among manufacturers further stimulate market expansion, ensuring a steady pipeline of cutting-edge retinal surgical solutions.

Retinal Surgery Devices Market Trends:

Rising Eye Disorder Prevalence

The increasing global prevalence of vision-related disorders among the masses is a major catalyst for growth in the market. Conditions such as macular degeneration, retinitis pigmentosa, and diabetic retinopathy are becoming more widespread, especially among diabetic and aging populations across the globe. Along with this, diabetic retinopathy alone affects 25.2% of individuals living with diabetes worldwide, with a significantly higher occurrence in type 1 diabetics (approximately 75%) compared to 50% in type 2 diabetics. According to the retinal surgery devices market forecast, these alarming statistics are pushing the demand for effective and efficient surgical solutions. The rise in cases requiring precise treatment is leading to increased adoption of retinal surgery devices, which are considered cost-effective, time-saving, and highly efficient during procedures. With a growing global diabetic population, this trend is expected to persist, supporting market expansion. In response, healthcare providers are prioritizing early diagnosis and advanced surgical interventions to manage progressive eye diseases effectively.

Geriatric Population and Age-Related Vision Loss

The aging demographic worldwide is another prominent factor enhancing the retinal surgery devices market demand. Elderly individuals are more susceptible to age-related ocular diseases such as cataracts, glaucoma, and presbyopia. Cataract prevalence provides a clear example: among individuals aged 45-54, the condition affects 4% of females and 2.4% of males, which dramatically increases to 30.49% in females and 27.97% in males aged 75 and above. As the global population continues to age, the healthcare sector is experiencing a corresponding rise in the need for advanced surgical interventions tailored to the unique requirements of older patients. Retinal surgery devices offer significant benefits, including less pain, minimal scarring, and quicker recovery times, which are particularly appealing for geriatric patients. This demography's growing vulnerability to chronic vision issues is encouraging healthcare systems and device manufacturers to invest in technologies that improve outcomes while ensuring comfort and safety for older individuals. Therefore, this is further creating a positive retinal surgery devices market outlook.

Technological Advancements and Rising Diabetes Incidence

Technological progress in minimally invasive surgical tools and equipment is significantly shaping the future of the retinal surgery devices market. Simultaneously, the steep rise in global diabetes cases is creating further demand for specialized eye care solutions. According to the International Diabetes Federation (IDF), nearly 589 million adults currently live with diabetes, a number projected to rise to 853 million by 2050. This chronic condition contributes to more than 3.4 million deaths each year and is a key driver behind the increasing cases of diabetic retinopathy and related vision issues. The shift towards minimally invasive surgeries aligns with the broader push for better patient outcomes, faster recovery, and enhanced safety. Innovations in retinal surgery devices are offering these benefits while catering to the growing diabetic population's unique medical needs. As awareness of treatment options spreads globally, this convergence of technological innovation and health demographics is propelling market growth.

Retinal Surgery Devices Industry Segmentation:

Analysis by Equipment Type:

Vitrectomy Machines
Retinal Laser Equipment
Surgical Instruments
- Cannulas
- Forceps
- Cutters
- Cryoprobes
- Others

Vitrectomy machines stand as the largest component in 2024, holding around 44.8% of the market, driven by their critical role in treating complex retinal conditions, such as diabetic retinopathy, retinal detachment, and macular holes. These advanced systems enable precise removal of vitreous gel and scar tissue while minimizing trauma to surrounding structures, improving surgical outcomes. According to the retinal surgery devices market research report, the shift toward minimally invasive vitrectomy surgery (MIVS) with smaller-gauge instruments has further increased adoption, reducing recovery times and complications. Technological advancements, including high-speed cutters, integrated fluidics, and enhanced visualization systems, enhance surgical efficiency and safety. Additionally, the rising prevalence of retinal diseases, an aging population, and increasing diabetic cases contribute to sustained demand. Leading manufacturers continue to innovate, introducing portable and user-friendly systems that expand accessibility in both hospitals and ambulatory surgical centers. With superior efficacy and expanding applications, vitrectomy machines remain indispensable in retinal surgery, securing their position as the leading equipment type in the market.

Analysis by Application:

Diabetic Retinopathy
Retinal Detachment
Others

Diabetic retinopathy leads the market with around 40.6% of market share in 2024, primarily due to the escalating global prevalence of diabetes and its associated ocular complications. As a leading cause of vision loss among working-age adults, this progressive condition demands advanced surgical interventions such as vitrectomy and laser photocoagulation to manage vitreous hemorrhages, retinal detachment, and macular edema. The growing diabetic population, coupled with poor glycemic control in many patients, fuels the need for early and aggressive treatment, driving demand for specialized retinal surgery devices. Additionally, increasing awareness about diabetes-related eye complications and improved screening programs have led to earlier diagnosis, expanding the patient pool requiring surgical care. Technological advancements in imaging and microsurgical tools further enhance treatment precision, supporting segment growth. With diabetes rates continuing to rise worldwide, particularly in aging populations, diabetic retinopathy is expected to maintain its dominance as the key application driving the retinal surgery devices market.

Analysis by End-Use:

Hospitals
Ophthalmology Clinics
Others

Hospitals lead the market with around 60.1% of market share in 2024, due to their advanced infrastructure, availability of skilled ophthalmologists, and ability to handle complex retinal procedures. Equipped with state-of-the-art operating rooms and diagnostic tools, hospitals are the primary settings for vitrectomies, retinal detachment repairs, and other intricate eye surgeries. The increasing prevalence of retinal disorders, coupled with rising hospital admissions for vision-related conditions, further drives demand in this segment. Additionally, hospitals often serve as referral centers for specialized ophthalmic care, attracting patients requiring advanced surgical interventions. The growing adoption of minimally invasive retinal surgeries in hospital settings, supported by favorable reimbursement policies, also contributes to segment dominance. With continuous investments in healthcare infrastructure and the integration of cutting-edge surgical technologies, hospitals remain the preferred choice for retinal treatments, reinforcing their position as the leading end-use segment in the market.

Regional Analysis:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

In 2024, North America accounted for the largest market share of over 35%, driven by advanced healthcare infrastructure, high adoption of innovative surgical technologies, and a significant patient pool suffering from retinal disorders. The region's leadership is reinforced by the rising prevalence of diabetes and age-related macular degeneration (AMD), increasing demand for vitrectomy and other retinal procedures. Well-established reimbursement policies, particularly in the U.S., enhance patient access to advanced treatments, while strong R&D investments by key industry players accelerate product development. Additionally, the presence of leading ophthalmic centers and skilled surgeons supports the adoption of cutting-edge devices. High awareness about retinal health and proactive screening programs further contribute to early diagnosis and surgical intervention. With continuous technological advancements and favorable regulatory frameworks, North America remains the largest and most influential regional segment in the global retinal surgery devices market.

Key Regional Takeaways:

United States Retinal Surgery Devices Market Analysis

In 2024, the US accounted for around 85.80% of the total North America retinal surgery devices market. The United States market is primarily driven by the increasing prevalence of retinal disorders, including age-related macular degeneration (AMD) and diabetic retinopathy. According to the CDC, in 2021, approximately 9.6 million individuals in the United States were affected by diabetic retinopathy (DR). Among them, 1.84 million were experiencing vision-threatening forms of DR. In line with this, continual advancements in retinal imaging and diagnostic technologies, enabling earlier detection and more accurate treatment of retinal conditions, are propelling market growth. Furthermore, the rising aging population, which is more susceptible to retinal diseases, is contributing to market demand. Additionally, the growing adoption of minimally invasive procedures, with these techniques offering quicker recovery times and reduced risks, is driving the market expansion. The enhanced surgical outcomes facilitated by innovations in retinal surgery devices, such as improved lasers and surgical microscopes, are stimulating market appeal. Similarly, the increased awareness of retinal diseases and advancements in personalized medicine are expanding the market scope. Moreover, favorable reimbursement policies and government initiatives promoting eye health are creating lucrative opportunities in the market.

Europe Retinal Surgery Devices Market Analysis

The market in Europe is experiencing growth due to increasing geriatric population leading to a higher prevalence of age-related macular degeneration and diabetic retinopathy. As per an industry report, in Europe, age-related macular degeneration (AMD) affects about 67 million individuals, projected to reach 77 million by 2050. Prevalence rises from 5% in ages 55-64 to 17.4% in those over 85, with 1.4 late-stage AMD cases per 1,000 individuals aged 60+, annually. Similarly, enhanced reimbursement policies in key European countries are making retinal procedures more accessible in the market. The growing adoption of minimally invasive vitreoretinal surgery techniques fueling the need for precision instruments, is fostering market expansion. Furthermore, continuous innovation by European manufacturers in micro-incision and illumination technologies is accelerating higher product uptake. The rising awareness campaigns and proactive screening initiatives improving early diagnosis rates are enhancing market appeal. Additionally, the expansion of ophthalmology training programs contributing to a skilled workforce, enabling the safe use of complex devices, is bolstering market development. Besides this, numerous cross-border healthcare collaborations and harmonized regulatory frameworks within the EU encouraging product approvals and regional distribution, are providing an impetus to the market.

Asia Pacific Retinal Surgery Devices Market Analysis

The Asia Pacific market is being propelled by the changing lifestyles, rising diabetes rates, and increasing diabetic retinopathy cases. According to NCBI, the number of individuals with diabetes in India rose sharply from 33 million in 2000 to 72 million in 2021 and is expected to reach 125 million by 2045. In accordance with this, rising investments in public and private healthcare infrastructure, improving access to advanced ophthalmic procedures, are supporting market expansion. The increasing presence of a large patient pool and rising disposable incomes is increasing the affordability and demand in the market. Furthermore, the expansion of medical tourism across Southeast Asia, heightening the requirement for cutting-edge retinal surgical technologies, is a significant market driver. Additionally, the growing presence of device makers in the region, augmenting access to innovative retinal surgery tools suited to local needs, is impelling the market. Moreover, favorable government-led health initiatives in countries including India and China, promoting eye health awareness and early detection, are impacting the market dynamics.

Latin America Retinal Surgery Devices Market Analysis

In Latin America, the market is advancing due to increasing rates of chronic eye conditions such as retinal detachment and macular holes, particularly in aging populations. Furthermore, various government-led efforts to expand universal healthcare coverage are enhancing access to ophthalmic surgeries in the market. As per NCBI, 14.14% of the population in Latin America suffers from moderate to severe vision impairment and blindness. Blindness is most prevalent in Tropical Latin America at 3.89%, and least in Southern Latin America at 0.96%. The rising awareness about preventable blindness fostering early diagnosis and timely interventions, is propelling the market growth. In addition to this, numerous regional partnerships with global manufacturers are driving advanced surgical tech and training adoption, augmenting outcomes in public and private care.

Middle East and Africa Retinal Surgery Devices Market Analysis

The market in the Middle East and Africa is significantly progressing attributed to the growing burden of inherited retinal disorders. Similarly, increasing penetration of vision care services in underserved rural areas, expanding the treatment base, is impelling development in the market. Furthermore, the rising prevalence of hypertension and lifestyle-related conditions is leading to a rise in retinal vascular complications is driving the need for precision retinal surgery tools and advanced diagnostic equipment, thereby expanding market reach. According to NCBI, hypertension affects approximately 36% of the general population in the African region. Apart from this, strategic collaborations with international ophthalmic organizations, enhancing clinical training and knowledge transfer, are influencing the market dynamics.

Competitive Landscape:

The competitive landscape of the market is characterized by intense rivalry among key players striving to strengthen their market position. Companies are focusing on technological advancements, launching next-generation devices with enhanced precision, efficiency, and minimally invasive capabilities. Strategic collaborations, mergers, and acquisitions are common as firms aim to expand their product portfolios and geographic reach. Investments in research and development are prioritized to introduce innovative solutions for complex retinal conditions. Additionally, players are emphasizing regulatory approvals and clinical validations to ensure product efficacy and safety. Marketing strategies include educational initiatives to raise awareness among healthcare professionals, while competitive pricing and after-sales support further drive adoption. The market also sees a growing emphasis on portable and user-friendly systems to cater to diverse clinical settings, reinforcing competition.

The report provides a comprehensive analysis of the competitive landscape in the retinal surgery devices market with detailed profiles of all major companies, including:

Alcon Management S. A.
Bausch & Lomb Incorporated
Carl Zeiss
Ellex Medical Lasers
Erbe Elektromedizin
Escalon Medicals
Iridex Corporation
Leica Microsystems GmbH
Lumenis
Nidek Co. Ltd.
Optos PLC
Second Sigh Medical Products
Synergetics USA Inc.
Topcon Corporation

Key Questions Answered in This Report

1.How big is the retinal surgery devices market?
2.What is the future outlook of the retinal surgery devices market?
3.What are the key factors driving the retinal surgery devices market?
4.Which region accounts for the largest retinal surgery devices market share?
5.Which are the leading companies in the global retinal surgery devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Retinal Surgery Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Equipment Type

6.1 Vitrectomy Machines
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Retinal Laser Equipment
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Surgical Instruments
- 6.3.1 Market Trends
- 6.3.2 Major Types
  - 6.3.2.1 Cannulas
  - 6.3.2.2 Forceps
  - 6.3.2.3 Cutters
  - 6.3.2.4 Cryoprobes
  - 6.3.2.5 Others
- 6.3.3 Market Forecast

7 Market Breakup by Application

7.1 Diabetic Retinopathy
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Retinal Detachment
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by End-Use

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Ophthalmology Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Alcon Management S. A.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Bausch & Lomb Incorporated
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 SWOT Analysis
- 14.3.3 Carl Zeiss
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Ellex Medical Lasers
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Erbe Elektromedizin
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
- 14.3.6 Escalon Medicals
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Iridex Corporation
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
- 14.3.8 Leica Microsystems GmbH
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Lumenis
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 SWOT Analysis
- 14.3.10 Nidek Co. Ltd.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 SWOT Analysis
- 14.3.11 Optos PLC
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
- 14.3.12 Second Sigh Medical Products
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
- 14.3.13 Synergetics USA Inc.
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
- 14.3.14 Topcon Corporation
  - 14.3.14.1 Company Overview
  - 14.3.14.2 Product Portfolio
  - 14.3.14.3 Financials

網膜手術装置の市場規模、シェア、動向、予測：機器タイプ別、用途別、最終用途別、地域別、2025年～2033年

Retinal Surgery Devices Market Size, Share, Trends and Forecast by Equipment Type, Application, End-Use, and Region, 2025-2033

網膜手術装置市場動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の網膜手術装置市場

第6章 市場内訳：機器タイプ別

第7章 市場内訳：用途別

第8章 市場内訳：最終用途別

第9章 市場内訳：地域別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格指標

第14章 競合情勢